Cellular interactions in the pathogenesis of interstitial lung diseases

被引:229
作者
Bagnato, Gianluca [1 ]
Harari, Sergio [2 ]
机构
[1] Univ Messina, Azienda Osped Univ Gaetano Martino, Dipartimento Med Clin & Sperimentale, Unita Operativa Reumatol, Messina, Italy
[2] Osped San Giuseppe MultiMed, Serv Fisiopatol Resp Emodinam Polmonare, Unita Operativa Pneumol & Terapia Semi Intensiva, Milan, Italy
关键词
D O I
10.1183/09059180.00003214
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Interstitial lung disease (ILD) encompasses a large and diverse group of pathological conditions that share similar clinical, radiological and pathological manifestations, despite potentially having quite different aetiologies and comorbidities. Idiopathic pulmonary fibrosis (IPF) represents probably the most aggressive form of ILD and systemic sclerosis is a multiorgan fibrotic disease frequently associated with ILD. Although the aetiology of these disorders remains unknown, in this review we analyse the pathogenic mechanisms by cell of interest (fibroblast, fibrocyte, myofibroblast, endothelial and alveolar epithelial cells and immune competent cells). New insights into the complex cellular contributions and interactions will be provided, comparing the role of cell subsets in the pathogenesis of IPF and systemic sclerosis.
引用
收藏
页码:102 / 114
页数:13
相关论文
共 135 条
[91]   FoxO3a (Forkhead Box O3a) Deficiency Protects Idiopathic Pulmonary Fibrosis (IPF) Fibroblasts from Type I Polymerized Collagen Matrix-Induced Apoptosis via Caveolin-1 (cav-1) and Fas [J].
Nho, Richard Seonghun ;
Peterson, Mark ;
Hergert, Polla ;
Henke, Craig A. .
PLOS ONE, 2013, 8 (04)
[92]   T cells in systemic sclerosis: a reappraisal [J].
O'Reilly, Steven ;
Huegle, Thomas ;
van Laar, Jacob M. .
RHEUMATOLOGY, 2012, 51 (09) :1540-1549
[93]   Interstitial lung disease in systemic sclerosis [J].
Ostojic, Predrag ;
Cerinic, Marco Matucci ;
Silver, Richard ;
Highland, Kristin ;
Damjanov, Nemanja .
LUNG, 2007, 185 (04) :211-220
[94]   Are mast cells instrumental for fibrotic diseases? [J].
Overed-Sayer, Catherine ;
Rapley, Laura ;
Mustelin, Tomas ;
Clarke, Deborah L. .
FRONTIERS IN PHARMACOLOGY, 2014, 4
[95]   The myofibroblast in pulmonary fibrosis [J].
Phan, SH .
CHEST, 2002, 122 (06) :286S-289S
[96]   A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18 [J].
Prasse, A ;
Pechkovsky, DV ;
Toews, GB ;
Jungraithmayr, W ;
Kollert, F ;
Goldmann, T ;
Vollmer, E ;
Müller-Quernheim, J ;
Zissel, G .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 173 (07) :781-792
[97]   CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis [J].
Prasse, Antje ;
Pechkovsky, Dmitri V. ;
Toews, Galen B. ;
Schaefer, Markus ;
Eggeling, Stephan ;
Ludwig, Corinna ;
Germann, Martin ;
Kollert, Florian ;
Zissel, Gernot ;
Mueller-Quernheirn, Joachim .
ARTHRITIS AND RHEUMATISM, 2007, 56 (05) :1685-1693
[98]  
RAGHU G, 1985, AM REV RESPIR DIS, V131, P281, DOI 10.1164/ajrccm/138.3.703
[99]   Oxidative stress and regulation of glutathione in lung inflammation [J].
Rahman, I ;
MacNee, W .
EUROPEAN RESPIRATORY JOURNAL, 2000, 16 (03) :534-554
[100]   Comparing the differential effects of LPA on the barrier function of human pulmonary endothelial cells [J].
Ren, Yonglin ;
Guo, Liang ;
Tang, Xiaoyan ;
Apparsundaram, Subramaniam ;
Kitson, Christopher ;
Deguzman, Jeremy ;
Fuentes, Maria E. ;
Coyle, Luke ;
Majmudar, Rupal ;
Allard, John ;
Truitt, Theresa ;
Hamid, Rachid ;
Chen, Yun ;
Qian, Yimin ;
Budd, David C. .
MICROVASCULAR RESEARCH, 2013, 85 :59-67